首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR INHALATION FOR TREATING A RESPIRATORY DISEASE, USE THEREOF AND METHOD OF TREATING A RESPIRATORY DISEASE

PHARMACEUTICAL COMPOSITION FOR INHALATION FOR TREATING A RESPIRATORY DISEASE, USE THEREOF AND METHOD OF TREATING A RESPIRATORY DISEASE

机译:吸入药物治疗呼吸系统疾病的药物组合物,其用途和治疗呼吸系统疾病的方法

摘要

The present invention relates to a pharmaceutical composition for inhalation for treating a respiratory disease comprising an active ingredient and a carrier, wherein the active ingredient comprises micronised formoterol fumarate and micronised budesonide, and wherein the carrier comprises lactose having the following particle size distribution: d10=20-65 μm, d50=80-120 μm, d90=130-180 μm and less than 10% of the particles have the size less than 10 μm. The present invention also relates to a method of treating a respiratory disease comprising delivering said pharmaceutical composition to a patient using a dry powder inhaler and to the use of said pharmaceutical composition for treating a respiratory disease and for preparing a medicament for treating a respiratory disease. The technical result of the present invention consists in providing an appropriate dose and fine particle mass of a medicament over the lifetime of the inhaler.
机译:本发明涉及用于治疗呼吸道疾病的吸入药物组合物,其包含活性成分和载体,其中所述活性成分包含微粉化的富马酸福莫特罗和微粉化的布地奈德,并且其中所述载体包含具有以下粒度分布的乳糖: 20-65μm,d50 =80-120μm,d90 =130-180μm,小于10%的颗粒的尺寸小于10μm。本发明还涉及一种治疗呼吸道疾病的方法,该方法包括使用干粉吸入器将所述药物组合物递送给患者,并且涉及所述药物组合物在治疗呼吸道疾病和制备用于治疗呼吸道疾病的药物中的用途。本发明的技术结果在于在吸入器的使用寿命内提供适当剂量和细颗粒的药物。

著录项

  • 公开/公告号EA034245B1

    专利类型

  • 公开/公告日2020-01-21

    原文格式PDF

  • 申请/专利权人 PHARMACHEMIE B.V.;

    申请/专利号EA20150090738

  • 发明设计人 JAN;JOHAN;MICHAEL IMRE;

    申请日2014-11-19

  • 分类号A61M15;A61K9;A61K31/167;A61K31/58;

  • 国家 EA

  • 入库时间 2022-08-21 11:17:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号